Mr. Ian Wilson has over 30 years of experience in development of in vivo medical diagnostics and imaging medical devices, he is a highly established and influential member of the industry and has built an enviable skill-set over the years through a number of significant healthcare roles.
It’s this diverse portfolio of skills, along with his aspirational vision of growing ImaginAb to transform the healthcare and biotechnology industry that has led Mr. Wilson to accelerate ImaginAb’s business presence and performance for the last 6 years
Priort to imaginAb, he was the CEO and CTO of Edinburgh Molecular Imaging Ltd, leading the development of novel optical imaging agents to improve cancer detection, surgery and lung disease.
Prior to that, he held several roles at GE Healthcare between 1996 and 2013, including Portfolio and Strategy Manager and Head of Biology, with responsibility for management of GE Healthcare’s Molecular Imaging Agent Portfolio, in Cardiovascular, Oncology and Neurology, and strategic and tactical oversight.
He had responsibility for supporting efficacy and regulatory studies required for the approval of new imaging agents. At Xstrahl Ltd, as CTO &COO, he was responsible for the oversight of the Radiotherapy commercial operation and manufacture oversight, including new product development.
